Wealthcare Advisory Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Wealthcare Advisory Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-880	Closed	-$11K	–	1559
2021 Q1	$11K	Buy	+880	New	+$11.3K	﹤0.01%	1429
2020 Q2	–	Sell	-875	Closed	-$7K	–	1114
2020 Q1	$7K	Hold	875	–	–	﹤0.01%	1019
2019 Q4	$7K	Hold	875	–	–	﹤0.01%	1044
2019 Q3	$7K	Buy	+875	New	+$6.51K	﹤0.01%	1011

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wealthcare Advisory Partners's RDY Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 880 shares — an estimated $11K sold.

Wealthcare Advisory Partners first reported a position in RDY in Q3 2019 and held it in 4 quarters. The position peaked at $11K in Q1 2021. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 880 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $11K.
Wealthcare Advisory Partners first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 4 quarters.
Wealthcare Advisory Partners's Dr. Reddy's Laboratories position peaked at $11K in Q1 2021.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.